Domzalski David 4

What Happened

• David Domzalski, President & CEO and a director of VYNE Therapeutics (VYNE), had 14,232 shares withheld by the issuer on 2026-03-31 to satisfy tax withholding in connection with the vesting of restricted stock units. The reported per-share amount was $0.60, for a withholding value of $8,504. This is a tax-withholding disposition (code F), a routine administrative action rather than an open-market sale or purchase.

Key Details

• Transaction date: 2026-03-31
• Transaction type/code: Payment of tax liability via share withholding (F)
• Shares withheld/disposed: 14,232 at $0.60 per share
• Reported value of shares withheld: $8,504
• Footnote: F1 — shares were withheld by the issuer to satisfy tax withholding requirements on RSU vesting
• Shares owned after transaction: not specified in the Form 4 filing
• Filing date: 2026-04-02 (filed within normal Form 4 timing; not marked late)

Context

• This was a tax-withholding event tied to RSU vesting (issuer withheld shares to cover taxes). It is an administrative transaction and does not by itself signal a deliberate buy or sell decision by the insider. For the full picture of Domzalski’s holdings and prior awards, review the complete Form 4 and company disclosures.